CPAY vs CRL · P/E 21, rev $2.60B vs rev $2.00B
Corpay Inc (CPAY) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Corpay Inc (CPAY) is a software - infrastructure company listed on NYSE.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported CPAY revenue for 2026-06-30 was $2.60B. Net income was $598.4M. CPAY currently screens at market cap $23.09B and trailing P/E 21.2.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
CPAY currently screens at market cap $23.09B and trailing P/E 21.2. CRL currently screens at market cap $7.78B.
Not investment advice. Open the CPAY and CRL stock pages for the full models.
Not investment advice.